BSEInsider Trading / SAST2d ago · 23 Sept 2026, 11:21 am
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Krishna Institute of Medical Sciences Ltd · 543308
✦ AI SummaryPledge
Catalyst Trusteeship Limited has acquired 2,80,08,979 shares of Krishna Institute of Medical Sciences Ltd through pledge of equity shares by Bhaskara Rao Bollineni and Bollineni Seenaiah Naidu in favour of Catalyst Trusteeship Limited.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Krishna Institute of Medical Sciences Ltd - 543308 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Attachments (1)
📄pdf
Download →
3194457B_55E2_46B6_A0EE_8CD8AC39C00A_112150.pdf
View document text
3) KRISHNA INSTITUTE OF MEDICAL SCIENCES LIMITED
D.NO.1-8-
SECUNDERABAD-3, ANDHRA PRADESH,
Telangana, India -500003.
Sub: Disclosure pursuant to Regulation 29(1) of the SEBI (Substantial Acquisition of Shares and
Takeovers) Regulations, 2011 in relation to pledge of equity shares of KRISHNA INSTITUTE OF
MEDICAL SCIENCES LIMITED
For Catalyst Trusteeship Limited
AuthorisedSignatory
Name: Deesha Srikkanth
Designation: Senior Vice President
Place: Mumbai
Date: 22 September 2026
Part A
Annexure
Disclosures under Regulation 29(1) of Securities and Exchange Board of India
(Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Part-A-Details of the Acquisition
1. Name of the Target Company (TC) KRISHNA INSTITUTE OF MEDICAL SCIENCES
LIMITED
2.Name(s) of the acquirer and Persons Acting in Catalyst Trusteeship Limited acting as Debenture
Concert (PAC) with the acquirer Trustee on behalf of Debentureholders
3.Whether the acquirer belongs to No.
Promoter/Promoter group
4.Name(s) of the Stock Exchange(s) where the shares BSE Limited and National Stock Exchange of India
of TC are Listed Limited
5.Details of the acquisition as follows Number % w.r.t. total % w.r.t. total
share/voting diluted
capital wherever share/voting
applicable(*) capital of the TC
(**)
Before the acquisition under consideration, holding
of acquirer along with PACs of:
a) Shares carrying voting rights - - -
b) Shares in the nature of encumbrance - - -
(pledge/lien/non-disposal undertaking/others)
c) Voting rights (VR) otherwise than by shares - - -
d) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying voting rights in the TC
(specify holding in each category)
e) Total (a+b+c+d) - - -
Details of acquisition
a) Shares carrying voting rights acquired - - -
b) VRs acquired otherwise than by equity shares - - -
c) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive
shares carrying category) acquired
d) Shares in nature of encumbrance (pledge/lien 2,80,08,979 6.66 6.66
/non-disposal undertaking/others)
e) Total (a+b+c+d) 2,80,08,979 6.66 6.66
After the acquisition, holding of acquirer along with
PACs of:
a) Shares carrying voting rights - - -
b) VRs otherwise than by equity shares - - -
c) Warrants/convertible securities/any other - - -
instrument that entitles the acquirer to receive shares
carrying voting rights in the TC (specify holding in
each category) after acquisition
d) Shares in nature of encumbrance 2,80,08,979 6.66 6.66
(pledge/lien/non-disposal undertaking/others)
e) Total (a+b+c+d) 2,80,08,979 6.66 6.66
6.Mode of acquisition (e.g. open market / public By way of pledge of equity shares of the Target
issue / rights issue / preferential allotment / inter-se Company in favour of Catalyst Trusteeship Limited
transfer/encumbrance, etc.)
7.Salient features of the securities acquired including Pledge over 2,80,08,979 equity shares of the Target
time till redemption, ratio at which it can be Company by Bhaskara Rao Bollineni and Bollineni
converted into equity shares, etc. Seenaiah Naidu in favour of Catalyst Trusteeship
Limited acting as Debenture Trustee on behalf of
Debenture holders.
8.Date of acquisition of/ date of receipt of intimation 18-Sep-2026
of allotment of shares / VR/ warrants/convertible
securities/any other instrument that entitles the
acquirer to receive shares in the TC.
Rs. 84,00,12,968 (42,00,06,484 Equity shares having
9.Equity share capital / total voting capital of the TC
face value of Rs 2 each)
before the said acquisition
Rs. 84,00,12,968 (42,00,06,484 Equity shares having
10.Equity share capital/ total voting capital of the TC
face value of Rs 2 each)
after the said acquisition
Rs. 84,00,12,968 (42,00,06,484 Equity shares having
11.Total diluted share/voting capital of the TC after
face value of Rs 2 each)
the said acquisition
Signature of the acquirer:
For Catalyst Trusteeship Limited
AuthorisedSignatory
Name: Deesha Srikkanth
Designation: Senior Vice President
Place: Mumbai
Date: 22 September 2026